Arachidonic acid as a target for treating hypertriglyceridemia reproduced by a causal network analysis and an intervention study
Metabolomics
.
2018 May 26;14(6):78.
doi: 10.1007/s11306-018-1368-2.
Authors
Azam Yazdani
1
2
,
Akram Yazdani
3
4
,
Thomas A Bowman
5
,
Francesco Marotta
6
,
John P Cooke
7
,
Ahmad Samiei
3
8
Affiliations
1
University of Texas, Health Science Center, Houston, TX, 77030, USA. a.mandana.yazdani@gmail.com.
2
Climax Data Pattern, Houston, TX, USA. a.mandana.yazdani@gmail.com.
3
Climax Data Pattern, Houston, TX, USA.
4
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, 10029, USA.
5
Jarrow Formulas, Inc., 1824 S. Robertson Blvd, Los Angeles, CA, 90035, USA.
6
ReGenera Research Group for Aging Intervention, Milan, Italy.
7
Department of Cardiovascular Sciences, Houston Methodist, Houston, USA.
8
Hasso Plattner Institute, 14482, Potsdam, Germany.
PMID:
30830364
DOI:
10.1007/s11306-018-1368-2
No abstract available
Publication types
Letter
MeSH terms
Arachidonic Acid / metabolism*
Bayes Theorem
Clinical Trials as Topic
Early Medical Intervention
Humans
Hypertriglyceridemia / metabolism
Hypertriglyceridemia / prevention & control*
Metabolic Networks and Pathways*
Substances
Arachidonic Acid
Grants and funding
RP140113/Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia/International